Catalyst /
Beijing Continent Pharmaceuticals Co., Ltd
Catalyst takes controlling interest in Beijing Continent Pharmaceuticals, Co., Ltd.
What happened
Catalyst acquired an indirect controlling interest in Beijing Continent Pharmaceuticals Co., Ltd. as part of the business combination completed on Oct. 30, 2023.
Beijing Continent Pharmaceuticals mainly sells pharmaceutical products to distributors in mainland China. Terms weren't disclosed.
The source
Everything on this page comes from the source below.
Catalyst takes controlling interest in Beijing Continent Pharmaceuticals, Co., Ltd.
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly